effexor xr

Generic: venlafaxine hydrochloride

Labeler: wyeth pharmaceuticals llc, a subsidiary of pfizer inc.
NDC Directory HUMAN PRESCRIPTION DRUG NDA Inactive Finished

Drug Facts

Product Profile

Brand Name effexor xr
Generic Name venlafaxine hydrochloride
Labeler wyeth pharmaceuticals llc, a subsidiary of pfizer inc.
Dosage Form CAPSULE, EXTENDED RELEASE
Routes
ORAL
Active Ingredients

venlafaxine hydrochloride 150 mg/1

Manufacturer
Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.

Identifiers & Regulatory

Product NDC 0008-0836
Product ID 0008-0836_3f8cf689-0fbb-4056-a85d-150dfd527313
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category NDA
Application Number NDA020699
Marketing Start 1997-11-01
Marketing End 2026-06-30

Pharmacologic Class

Classes
norepinephrine uptake inhibitors [moa] serotonin uptake inhibitors [moa] serotonin and norepinephrine reuptake inhibitor [epc]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 00080836
Hyphenated Format 0008-0836

Supplemental Identifiers

RxCUI
313581 313583 313585 729929 729931 729932
UNII
7D7RX5A8MO

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name effexor xr (source: ndc)
Generic Name venlafaxine hydrochloride (source: ndc)
Application Number NDA020699 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 150 mg/1
source: ndc
Packaging
  • 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (0008-0836-21)
source: ndc

Packages (1)

0008-0836-21 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (0008-0836-21)

Ingredients (1)

venlafaxine hydrochloride (150 mg/1)

Linked Drug Pages (1)

Effexor XR ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "3f8cf689-0fbb-4056-a85d-150dfd527313", "openfda": {"unii": ["7D7RX5A8MO"], "rxcui": ["313581", "313583", "313585", "729929", "729931", "729932"], "spl_set_id": ["53c3e7ac-1852-4d70-d2b6-4fca819acf26"], "manufacturer_name": ["Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (0008-0836-21)", "package_ndc": "0008-0836-21", "marketing_end_date": "20260630", "marketing_start_date": "19971101"}], "brand_name": "Effexor XR", "product_id": "0008-0836_3f8cf689-0fbb-4056-a85d-150dfd527313", "dosage_form": "CAPSULE, EXTENDED RELEASE", "pharm_class": ["Norepinephrine Uptake Inhibitors [MoA]", "Serotonin Uptake Inhibitors [MoA]", "Serotonin and Norepinephrine Reuptake Inhibitor [EPC]"], "product_ndc": "0008-0836", "generic_name": "VENLAFAXINE HYDROCHLORIDE", "labeler_name": "Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Effexor", "brand_name_suffix": "XR", "active_ingredients": [{"name": "VENLAFAXINE HYDROCHLORIDE", "strength": "150 mg/1"}], "application_number": "NDA020699", "marketing_category": "NDA", "marketing_end_date": "20260630", "marketing_start_date": "19971101"}